Journal article
Proteomics mining of cancer hallmarks on a single‐cell resolution
Mass spectrometry reviews, Vol.43(5), pp.1019-1040
09/2024
DOI: 10.1002/mas.21842
PMID: 37051664
Abstract
Dysregulated proteome is an essential contributor in carcinogenesis. Protein fluctuations fuel the progression of malignant transformation, such as uncontrolled proliferation, metastasis, and chemo/radiotherapy resistance, which severely impair therapeutic effectiveness and cause disease recurrence and eventually mortality among cancer patients. Cellular heterogeneity is widely observed in cancer and numerous cell subtypes have been characterized that greatly influence cancer progression. Population‐averaged research may not fully reveal the heterogeneity, leading to inaccurate conclusions. Thus, deep mining of the multiplex proteome at the single‐cell resolution will provide new insights into cancer biology, to develop prognostic biomarkers and treatments. Considering the recent advances in single‐cell proteomics, herein we review several novel technologies with particular focus on single‐cell mass spectrometry analysis, and summarize their advantages and practical applications in the diagnosis and treatment for cancer. Technological development in single‐cell proteomics will bring a paradigm shift in cancer detection, intervention, and therapy.
Details
- Title: Subtitle
- Proteomics mining of cancer hallmarks on a single‐cell resolution
- Creators
- Maomao Li - Sichuan UniversityJing Zuo - Sichuan UniversityKailin Yang - Cleveland ClinicPing Wang - Sichuan UniversityShengtao Zhou - Sichuan University
- Resource Type
- Journal article
- Publication Details
- Mass spectrometry reviews, Vol.43(5), pp.1019-1040
- DOI
- 10.1002/mas.21842
- PMID
- 37051664
- NLM abbreviation
- Mass Spectrom Rev
- ISSN
- 0277-7037
- eISSN
- 1098-2787
- Number of pages
- 22
- Language
- English
- Date published
- 09/2024
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984696718202771
Metrics
5 Record Views